NCT00902590Active, not recruiting
A Genotype-Phenotype Urothelial Cancer Registry
Source: ClinicalTrials.gov · Last updated 24 Aug 2026
Brief summary (registry, in English)
This study is being done to create a registry to help us learn more about urinary and other cancers. This will let us look at large groups of people who do and do not have this kind of cancer. The investigators will look at risk factors to learn more about how these impact cancer. The investigators will also look at genetic markers. These are genes that are found in a known place. They are often associated with a particular trait. If the gene changes in some way, it may predict cancer or response to treatment. The investigators will look for markers in your saliva. This registry will help us develop better methods of: Preventing these cancers. Diagnosing these cancers. Treating these cancers.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3519 (actual)
- First submitted
- 14 May 2009
- Start date
- May 2009
- Primary completion date
- 31 May 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Bladder cancer
- NCT number
- NCT00902590
What you commit to
- Study type: Observational
- Participants enrolled: 3519
- From May 2009 to the primary completion date, 31 May 2027
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have any condition, which in the opinion of the primary MSKCC clinician or investigators precludes their ability to provide informed consent.
Who the study is looking for
- Urothelial Cancer Cases
- Must be ≥ 18 years of age AND
- Must have a diagnosis of urothelial cancer AND
- Must be an English-speaker
- Non-Cancer Control Group
- Must be ≥ 18 years of age AND
- Must not have cancer or a personal history of cancer, with the exception of skin cancer. AND
- Must not be a blood relative of cases AND
- Must not be a blood relative of another control AND
- Must be an English-speaker
- Family Member Control Group:
- In select kindreds with a high prevalence of bladder cancer and/or very early onset bladder cancer, first- and second-degree family members of probands may be contacted by the MSKCC study team and invited to complete the questionnaire and submit a saliva sample.
- Must be ≥ 18 years of age AND
- Must be a blood relative of a case participant AND
- Must be an English-speaker
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge Coordinator of this site? Confirm its status | Basking Ridge | United States | Unknown status |
| Memorial Sloan Kettering Commack Coordinator of this site? Confirm its status | Commack | United States | Unknown status |
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Memorial Sloan Kettering Nassau Coordinator of this site? Confirm its status | Uniondale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.